Abstract: Described are methods for embedding one or more therapeutic agents into vascular grafts and other scaffold-based devices, and methods of implanting vascular grafts comprising tubular scaffolds into subjects. The tubular scaffolds comprise hydrogel nanofibers that have internally aligned polymer chains and may contain one or more therapeutic agents.

Abstract: The present invention features a composition that includes about 0.75% to about 1.25% by weight of a clay portion that comprises bentonite. The composition includes polymer particles having an average particle size of less than about 20 microns and a refractive index of about 1.3 to about 1.4. The composition is substantially free of hydrophobic compounds. The composition is useful for treating under eye skin.

Abstract: This invention relates to a novel composition and method useful for the treatment of acne, and more particularly, to a composition and method for reducing an appearance of post acne marks and scars without skin irritation in a short amount of time.

Abstract: The present invention relates to a composition suitable for topical application to skin to provide protection to the skin when exposed to UV radiation, the composition including a sunscreen in amounts effective to absorb, reflect or scatter radiation in at least a portion of the ultraviolet spectrum, a marine nucleotide in amounts effective to mitigate effects on intracellular ion concentration and a cosmetically-acceptable topical carrier.

Abstract: Methods are provided for the in vitro differentiation of one or both of adipocytes and osteoblasts from embryonic stem cells.

Abstract: An adenoviral vector which includes at least one DNA sequence encoding an angiogenic inhibitor, such as endostatin. Such vectors may be employed in treating diseases or disorders associated with angiogenesis, such as cancer, vascular diseases of the eye, including diabetic retinopathy, psoriasis, arthritis, cardiovascular disease, cerebral edema and Kasabach-Merritt syndrome.